Radiation Oncology/Therapy: Page 104

Sequential trastuzumab does poorly in European breast cancer study
By Reuters Health
NEW YORK (Reuters Health), Dec 3 - In women with axillary node-positive breast cancer, giving trastuzumab after the end of adjuvant chemotherapy and radiation did not significantly reduce their risk of relapse, European researchers report online in the Journal of Clinical Oncology.
December 2, 2009
Reuterslogo
Radiation of gangliogliomas is potentially useful only when total resection can't be done
By Reuters Health
NEW YORK (Reuters Health), Dec 3 - In a large series of patients with very rare gangliogliomas, gross total resection (GTR) provided the best outcomes. When only subtotal resection (STR) was possible -- as was often the case -- postoperative radiotherapy improved local control but not survival.
December 2, 2009
Reuterslogo
Male childhood cancer survivors at risk for hypogonadism: study
By Reuters Health
NEW YORK (Reuters Health), Nov 26 - Almost a quarter of adult men who have been treated for childhood cancer have hormone levels indicating testosterone deficiency, results of a Swedish study indicate.
November 25, 2009
Reuterslogo
Optical sensor tracks radiotherapy treatment site breast motion
By Paula Gould
Postsurgical radiotherapy is an effective way of preventing breast tumors from reappearing, but the downside is the mismatch between ideal treatment plans and the doses actually delivered. Although conformal methods of delivery could address this issue, switching delivery techniques raises another potential problem: Will breast motion compromise the accuracy of a highly targeted radiotherapy regimen?
November 25, 2009
2009 01 15 16 03 49 510 Med Phys Web Logo 100
Varian, Mirada sign supply pact
By AuntMinnieEurope.com staff writers
Radiation therapy firm Varian Medical Systems has signed a deal with medical imaging software developer Mirada Medical of Oxford, U.K., for the supply of multimodality image registration technologies.
November 16, 2009
Varian nets multifacility install in Portugal
By AuntMinnieEurope.com staff writers
Radiation therapy firm Varian Medical Systems has announced the sale of seven radiation therapy machines to the Instituto Português Oncologia in Porto, Portugal.
November 1, 2009
Specialized RT unnecessary for some breast cancer patients
By AuntMinnieEurope.com staff writers
CHICAGO - Breast cancer patients who receive radiation treatment to the lymph nodes located behind the breast bone do not have better survival outcomes than patients who don't receive radiation in this difficult-to-treat area.
November 1, 2009
IBA launches proton rental program
By AuntMinnieEurope.com staff writers
Radiopharmaceutical firm Ion Beam Applications (IBA) has launched a rental program designed to enable hospitals and cancer centers to offer proton therapy for their cancer patients.
October 29, 2009
Concurrent chemo + radiation increases survival in advanced head, neck cancer
By Reuters Health
NEW YORK (Reuters Health), Oct 29 - Giving chemotherapy during radiotherapy to patients with locally advanced, nonresected head or neck carcinoma nearly doubles their average overall survival and more than doubles their event-free survival, compared to giving the treatments separately, research indicates.
October 28, 2009
Reuterslogo
Risk of thyroid cancer increased in childhood cancer survivors
By Reuters Health
NEW YORK (Reuters Health), Oct 28 - Childhood cancer survivors are 18 times more likely to develop thyroid cancer than the general population, U.K. researchers report.
October 27, 2009
Reuterslogo
RT linked to hypothyroidism after breast cancer
By AuntMinnieEurope.com staff writers
Norwegian women who were treated with radiation therapy for stage II/III breast cancer had rates of thyroid disease as much as 300% higher than normal controls, according to a study published in the November issue of the International Journal of Radiation Oncology, Biology, Physics.
October 20, 2009
Premature delivery common after cancer diagnosis
By Reuters Health
NEW YORK (Reuters Health), Oct 20 - Iatrogenic preterm delivery is common among women diagnosed with invasive cancer during pregnancy, a new multicenter study shows. The study, published online in the Journal of Clinical Oncology, involved 215 women who received diagnoses of invasive cancers during pregnancy between 1998 and 2008.
October 19, 2009
Reuterslogo
Previous Page
Page 104 of 126
Next Page